Report Detail

Electronics & Semiconductor COVID-19 Impact on Global Human Organs-on-Chips Market Insights, Forecast to 2026

  • RnM4067507
  • |
  • 18 June, 2020
  • |
  • Global
  • |
  • 116 Pages
  • |
  • QYResearch
  • |
  • Electronics & Semiconductor

Human Organs-on-Chips market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Organs-on-Chips market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Human Organs-on-Chips market is segmented into
Liver-on-a-chip
Kidney-on-a-chip
Intestine-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Other Organs

Segment by Application, the Human Organs-on-Chips market is segmented into
Pharmaceutical & Biotechnology
Academic & Research Institutes
Cosmetics Industry
Other End Users

Regional and Country-level Analysis
The Human Organs-on-Chips market is analysed and market size information is provided by regions (countries).
The key regions covered in the Human Organs-on-Chips market report are North America, Europe, China, Japan and South Korea. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Human Organs-on-Chips Market Share Analysis

Human Organs-on-Chips market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Human Organs-on-Chips by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Human Organs-on-Chips business, the date to enter into the Human Organs-on-Chips market, Human Organs-on-Chips product introduction, recent developments, etc.
The major vendors covered:
Emulate
TissUse GmbH
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis Bio
Micronit
Kirkstall
Cherry Biotech


1 Study Coverage

  • 1.1 Human Organs-on-Chips Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Human Organs-on-Chips Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Human Organs-on-Chips Market Size Growth Rate by Type
    • 1.4.2 Liver-on-a-chip
    • 1.4.3 Kidney-on-a-chip
    • 1.4.4 Intestine-on-a-chip
    • 1.4.5 Lung-on-a-chip
    • 1.4.6 Heart-on-a-chip
    • 1.4.7 Other Organs
  • 1.5 Market by Application
    • 1.5.1 Global Human Organs-on-Chips Market Size Growth Rate by Application
    • 1.5.2 Pharmaceutical & Biotechnology
    • 1.5.3 Academic & Research Institutes
    • 1.5.4 Cosmetics Industry
    • 1.5.5 Other End Users
  • 1.6 Coronavirus Disease 2019 (Covid-19): Human Organs-on-Chips Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Human Organs-on-Chips Industry
      • 1.6.1.1 Human Organs-on-Chips Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Human Organs-on-Chips Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Human Organs-on-Chips Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Human Organs-on-Chips Market Size Estimates and Forecasts
    • 2.1.1 Global Human Organs-on-Chips Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Human Organs-on-Chips Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Human Organs-on-Chips Production Estimates and Forecasts 2015-2026
  • 2.2 Global Human Organs-on-Chips Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Human Organs-on-Chips Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Human Organs-on-Chips Manufacturers Geographical Distribution
  • 2.4 Key Trends for Human Organs-on-Chips Markets & Products
  • 2.5 Primary Interviews with Key Human Organs-on-Chips Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Human Organs-on-Chips Manufacturers by Production Capacity
    • 3.1.1 Global Top Human Organs-on-Chips Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Human Organs-on-Chips Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Human Organs-on-Chips Manufacturers Market Share by Production
  • 3.2 Global Top Human Organs-on-Chips Manufacturers by Revenue
    • 3.2.1 Global Top Human Organs-on-Chips Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Human Organs-on-Chips Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Human Organs-on-Chips Revenue in 2019
  • 3.3 Global Human Organs-on-Chips Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Human Organs-on-Chips Production by Regions

  • 4.1 Global Human Organs-on-Chips Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Human Organs-on-Chips Regions by Production (2015-2020)
    • 4.1.2 Global Top Human Organs-on-Chips Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Human Organs-on-Chips Production (2015-2020)
    • 4.2.2 North America Human Organs-on-Chips Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Human Organs-on-Chips Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Human Organs-on-Chips Production (2015-2020)
    • 4.3.2 Europe Human Organs-on-Chips Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Human Organs-on-Chips Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Human Organs-on-Chips Production (2015-2020)
    • 4.4.2 China Human Organs-on-Chips Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Human Organs-on-Chips Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Human Organs-on-Chips Production (2015-2020)
    • 4.5.2 Japan Human Organs-on-Chips Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Human Organs-on-Chips Import & Export (2015-2020)
  • 4.6 South Korea
    • 4.6.1 South Korea Human Organs-on-Chips Production (2015-2020)
    • 4.6.2 South Korea Human Organs-on-Chips Revenue (2015-2020)
    • 4.6.3 Key Players in South Korea
    • 4.6.4 South Korea Human Organs-on-Chips Import & Export (2015-2020)

5 Human Organs-on-Chips Consumption by Region

  • 5.1 Global Top Human Organs-on-Chips Regions by Consumption
    • 5.1.1 Global Top Human Organs-on-Chips Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Human Organs-on-Chips Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Human Organs-on-Chips Consumption by Application
    • 5.2.2 North America Human Organs-on-Chips Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Human Organs-on-Chips Consumption by Application
    • 5.3.2 Europe Human Organs-on-Chips Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Human Organs-on-Chips Consumption by Application
    • 5.4.2 Asia Pacific Human Organs-on-Chips Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Human Organs-on-Chips Consumption by Application
    • 5.5.2 Central & South America Human Organs-on-Chips Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Human Organs-on-Chips Consumption by Application
    • 5.6.2 Middle East and Africa Human Organs-on-Chips Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Human Organs-on-Chips Market Size by Type (2015-2020)
    • 6.1.1 Global Human Organs-on-Chips Production by Type (2015-2020)
    • 6.1.2 Global Human Organs-on-Chips Revenue by Type (2015-2020)
    • 6.1.3 Human Organs-on-Chips Price by Type (2015-2020)
  • 6.2 Global Human Organs-on-Chips Market Forecast by Type (2021-2026)
    • 6.2.1 Global Human Organs-on-Chips Production Forecast by Type (2021-2026)
    • 6.2.2 Global Human Organs-on-Chips Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Human Organs-on-Chips Price Forecast by Type (2021-2026)
  • 6.3 Global Human Organs-on-Chips Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Human Organs-on-Chips Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Human Organs-on-Chips Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 Emulate
    • 8.1.1 Emulate Corporation Information
    • 8.1.2 Emulate Overview and Its Total Revenue
    • 8.1.3 Emulate Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 Emulate Product Description
    • 8.1.5 Emulate Recent Development
  • 8.2 TissUse GmbH
    • 8.2.1 TissUse GmbH Corporation Information
    • 8.2.2 TissUse GmbH Overview and Its Total Revenue
    • 8.2.3 TissUse GmbH Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 TissUse GmbH Product Description
    • 8.2.5 TissUse GmbH Recent Development
  • 8.3 Hesperos
    • 8.3.1 Hesperos Corporation Information
    • 8.3.2 Hesperos Overview and Its Total Revenue
    • 8.3.3 Hesperos Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Hesperos Product Description
    • 8.3.5 Hesperos Recent Development
  • 8.4 CN Bio Innovations
    • 8.4.1 CN Bio Innovations Corporation Information
    • 8.4.2 CN Bio Innovations Overview and Its Total Revenue
    • 8.4.3 CN Bio Innovations Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 CN Bio Innovations Product Description
    • 8.4.5 CN Bio Innovations Recent Development
  • 8.5 Tara Biosystems
    • 8.5.1 Tara Biosystems Corporation Information
    • 8.5.2 Tara Biosystems Overview and Its Total Revenue
    • 8.5.3 Tara Biosystems Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Tara Biosystems Product Description
    • 8.5.5 Tara Biosystems Recent Development
  • 8.6 Draper Laboratory
    • 8.6.1 Draper Laboratory Corporation Information
    • 8.6.2 Draper Laboratory Overview and Its Total Revenue
    • 8.6.3 Draper Laboratory Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 Draper Laboratory Product Description
    • 8.6.5 Draper Laboratory Recent Development
  • 8.7 Mimetas
    • 8.7.1 Mimetas Corporation Information
    • 8.7.2 Mimetas Overview and Its Total Revenue
    • 8.7.3 Mimetas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 Mimetas Product Description
    • 8.7.5 Mimetas Recent Development
  • 8.8 Nortis Bio
    • 8.8.1 Nortis Bio Corporation Information
    • 8.8.2 Nortis Bio Overview and Its Total Revenue
    • 8.8.3 Nortis Bio Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 Nortis Bio Product Description
    • 8.8.5 Nortis Bio Recent Development
  • 8.9 Micronit
    • 8.9.1 Micronit Corporation Information
    • 8.9.2 Micronit Overview and Its Total Revenue
    • 8.9.3 Micronit Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 Micronit Product Description
    • 8.9.5 Micronit Recent Development
  • 8.10 Kirkstall
    • 8.10.1 Kirkstall Corporation Information
    • 8.10.2 Kirkstall Overview and Its Total Revenue
    • 8.10.3 Kirkstall Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 Kirkstall Product Description
    • 8.10.5 Kirkstall Recent Development
  • 8.11 Cherry Biotech
    • 8.11.1 Cherry Biotech Corporation Information
    • 8.11.2 Cherry Biotech Overview and Its Total Revenue
    • 8.11.3 Cherry Biotech Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.11.4 Cherry Biotech Product Description
    • 8.11.5 Cherry Biotech Recent Development
  • 8.12 Else Kooi Lab
    • 8.12.1 Else Kooi Lab Corporation Information
    • 8.12.2 Else Kooi Lab Overview and Its Total Revenue
    • 8.12.3 Else Kooi Lab Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.12.4 Else Kooi Lab Product Description
    • 8.12.5 Else Kooi Lab Recent Development

9 Production Forecasts by Regions

  • 9.1 Global Top Human Organs-on-Chips Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Human Organs-on-Chips Regions Forecast by Production (2021-2026)
  • 9.3 Key Human Organs-on-Chips Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan
    • 9.3.5 South Korea

10 Human Organs-on-Chips Consumption Forecast by Region

  • 10.1 Global Human Organs-on-Chips Consumption Forecast by Region (2021-2026)
  • 10.2 North America Human Organs-on-Chips Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Human Organs-on-Chips Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Human Organs-on-Chips Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Human Organs-on-Chips Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Human Organs-on-Chips Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Human Organs-on-Chips Sales Channels
    • 11.2.2 Human Organs-on-Chips Distributors
  • 11.3 Human Organs-on-Chips Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Market Opportunities and Drivers
  • 12.2 Market Challenges
  • 12.3 Market Risks/Restraints
  • 12.4 Porter's Five Forces Analysis

13 Key Finding in The Global Human Organs-on-Chips Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Human Organs-on-Chips. Industry analysis & Market Report on COVID-19 Impact on Global Human Organs-on-Chips is a syndicated market report, published as COVID-19 Impact on Global Human Organs-on-Chips Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Human Organs-on-Chips market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,900.00
    $7,350.00
    $9,800.00
    3,915.10
    5,872.65
    7,830.20
    4,571.70
    6,857.55
    9,143.40
    762,195.00
    1,143,292.50
    1,524,390.00
    408,317.00
    612,475.50
    816,634.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report